Figure 2.
A) Graphical display of absolute SCOUT frequency in controls, asymptomatic women with BRCA+ and women with serous carcinoma; B) normalized to allow for differences in sampling by showing SCOUT frequency as a function of tissue section examined. C) Multiple BCL2 positive SCOUTs in a section of normal tube (arrows) from a subject with serous carcinoma (See Table 2, samples 04).
